CL2008000668A1 -
Compounds derived from 3-cyano-4- (4-phenyl-piperidin-1-yl) pyridin-2-one; Preparation process; pharmaceutical composition that includes them; and its use to treat disorders of the central nervous system.
- Google Patents
Compounds derived from 3-cyano-4- (4-phenyl-piperidin-1-yl) pyridin-2-one; Preparation process; pharmaceutical composition that includes them; and its use to treat disorders of the central nervous system.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
Compuestos derivados de 3-ciano-4-(4-fenil-piperidin-1-il)-piridin-2-ona; composición farmacéutica que comprende a dichos compuestos; y su uso para tratar un trastorno del sistema nervioso central.Compounds derived from 3-cyano-4- (4-phenyl-piperidin-1-yl) -pyridin-2-one; pharmaceutical composition comprising said compounds; and its use to treat a disorder of the central nervous system.
CL2008000668A2007-03-072008-03-06
Compounds derived from 3-cyano-4- (4-phenyl-piperidin-1-yl) pyridin-2-one; Preparation process; pharmaceutical composition that includes them; and its use to treat disorders of the central nervous system.
CL2008000668A1
(en)
Compounds derived from 3-cyano-4- (4-phenyl-piperidin-1-yl) pyridin-2-one; Preparation process; pharmaceutical composition that includes them; and its use to treat disorders of the central nervous system.
COMPOUNDS DERIVED FROM [1,6] -NAFTIRIDINONE, MODULATORS OF KINASE ACTIVITY; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM; AND ITS USE TO TREAT PROLIFERATIVE, INFLAMMATORY, AUTO-IMMUNE DISORDERS, OF THE CENTRAL NERVOUS SYSTEM, AMONG OTHERS.
Compounds derived from 1,3-disubstituted-4-phenyl-1h-pyridin-2-one, allosteric modulators of the glutamatergic receptor mglur2; Pharmaceutical composition and use of the compounds in the treatment of neurological and psychiatric conditions mediated by mglur2.
COMPOUNDS DERIVED FROM ISOQUINOLINILO AND ISOINDOLINILO, ANTAGONISTAS DE HISTAMINA-3; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT NERVOUS SYSTEMS C
Compounds derived from heteroaryl pyridone and substituted aza-pyridone, btk kinase inhibitors; pharmaceutical composition that includes them; process of preparation of the pharmaceutical composition; pharmaceutical kit; and use for the treatment of immune disorders, cancer, inflammation, neurological disorders, among others.
Compounds derived from imidazo [1,2-a] pyridine, allosteric modulators of mglur2 receptors; pharmaceutical composition comprising said compounds; and its use in the preparation of medicaments to treat disorders of the central nervous system.
Compound derived from substituted pyrazolopyridine, lrrk2 kinase inhibitor; process of preparing said compound; pharmaceutical composition; pharmaceutical combination; use of the compound to prevent or treat a disorder selected from cancer and neurodegenerative diseases.
compound, use of the compound, pharmaceutical composition, and method for treating an individual suffering from a bruton tyrosine kinase (btk) mediated disorder
Compounds derived from carboxamide; pharmaceutical composition that includes them, and their use as inhibitors of phosphodiesterase type 10a (pde10a) for the treatment of CNS disorders, schizophrenia, cognitive dysfunction related to schizophrenia, bipolar disorders, depression, cognitive dysfunction, cognitive disorders, behavioral disorders associated with Alzheimer's disease, obesity, huntington's disease and anxiety.
COMPOUNDS DERIVED FROM PHENOTIAZINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT DIABETES, REDUCE THE LEVELS OF GLUCEMIA, ADDICTION TO NICOTINE, ADDICTION TO ALCOHOL, DISORDERS OF THE CENTRAL NERVOUS SYSTEM, BETWEEN